OCRA has invested $137 million toward finding a cure for ovarian and gynecologic cancers.

OCRA’s groundbreaking patient support programs help more than 95,000 people each year navigate an overwhelming diagnosis, aiding patients and families when they need it most.

OCRA advocates on Capitol Hill to improve research and education, drug and diagnostic safety, and access to quality care for all members of the ovarian and gynecologic cancer community. To date, OCRA has helped secure more than $3.8 billion in federal funding.